東軟集團(600718.SH):與瀋陽地鐵簽訂供貨合同
格隆匯8月26日丨東軟集團(600718.SH)公佈,2023年8月24日,公司十屆三次董事會審議通過了《關於與瀋陽地鐵集團有限公司簽訂合同的議案》,董事會同意公司與瀋陽地鐵集團有限公司(以下簡稱“瀋陽地鐵”)簽署項目合同。根據合同約定,公司承接瀋陽地鐵1號線東延線全線專用通信系統項目,合同總價款為59,898,058元人民幣;公司承接瀋陽地鐵3號線全線專用通信系統項目,合同總價款為192,098,058元人民幣。
公司為瀋陽地鐵提供包括傳輸子系統、公務電話子系統、專用電話子系統、視頻監視子系統、廣播子系統、時鐘子系統、乘客信息子系統、綜合佈線子系統和電源子系統及接地共計九個子系統的專用通信系統以及相關服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.